(Q48492310)

12 February 2018

title

CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

14 October 2022

author name string

McKernan RM

2

1 reference

12 February 2018

R. H. Hatfield

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606499

14 October 2022

R. M. McKernan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606499

14 October 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

12 February 2018

17 April 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1606499

full work available at URL

14 October 2022

https://api.elsevier.com/content/article/PII:000689939290280M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

https://api.elsevier.com/content/article/PII:000689939290280M?httpAccept=text/plain

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

14 October 2022

1 reference

12 February 2018

volume

577

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

249-252

1 reference

12 February 2018

Graded neurologic scale for use in acute hemispheric stroke treatment protocols

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Pathophysiology of cerebrospinal fluid in head injury: Part 2. Biochemical markers for central nervous system trauma

14 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.

14 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage

14 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid

14 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Cerebrospinal fluid enolase in stroke

14 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Highly sensitive immunoassays for three forms of rat brain enolase

14 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells

14 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue

14 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases

14 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats

14 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage

14 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.

14 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neurological Outcome After Out-of-Hospital Cardiac Arrest

14 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change

14 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Determination of brain 5-hydroxytryptamine turnover in freely moving rats using repeated sampling of cerebrovascular fluid

14 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Neuron-specific enolase as a marker of neuronal lesions during various comas in man.

14 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences.

14 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid

14 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage.

14 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage.

14 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

14 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90280-M

14 October 2022

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018